REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
30/03/2026
Voltar para busca
Dado oficial do USPTO
TANNQUILYNNE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
46
Atualização mais recente
31/03/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
09/05/2018
Data de registro
30/03/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
30/03/2021
Última transação
31/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
4
Tipo de titular
16
Localização do titular
GRAND CAYMAN, KY
Examinador
LIEBL, ALEXANDRA
Unidade examinadora
N20
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
S. N. (pessoa física)
SyneuRx International (Taiwan) Corp.
SyneuRx International (Taiwan) Corp.
Representantes
Michael T. Smith BIRCH STEWART KOLASCH & BIRCH LLP
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Therapeutic pharmaceutical for the treatment of neuropsychiatric disordersschizophreniadepressionattention deficit disordermild cognitive impairmentdementiabipolar disorderother central nervous system disorders; Phenol for pharmaceutical purposes; Plant extracts for medicalveterinary and pharmaceutical purposes; Syrups for pharmaceutical purposes for the treatment of dementia; Chemical preparations for pharmaceutical or medical purposesfor treating neuropsychiatric disordersschizophreniadepressionattention deficit disordermild cognitive impairmentdementiabipolar disorderother central nervous system disorders; Plant extracts for pharmaceutical purposes; Pharmaceutical preparations for treating sunburn; Chemical reagents for medical or veterinary purposes; Adjuvants for medical purposes; Animal feed additive for use as a nutritional supplement for medical purposes; Medicinal herbal extracts for medical purposes; Antibacterial substances for medical purposes; Transdermal patches featuring medication for the treatment of neuropsychiatric disordersschizophreniadepressionattention deficit disordermild cognitive impairmentdementiabipolar disorderother central nervous system disorders; Nutritional food additives for medical purposes in the nature of natural food extracts derived from plant; Herbal extracts for medical purposes; Phytotherapy preparations for medical purposes; Appetite suppressants for medical purposes; Beverages containing tannic acid for use as a nutritional supplement; Liquid nutritional supplement; Dietary and nutritional supplements; Nutritional supplements in the form of capsulestabletscapletspowdersyrupsgummies and gels; Powdered nutritional supplement drink mix; Nutritional supplement meal replacement bars for boosting energy; Nutritional supplements consisting primarily of tannic acid; Dietary and nutritional supplements used for weight loss; Nutritional supplement shakes; Nutritional and dietary supplements formed and packaged as bars; Nutritional supplements in capsule form for dogs; Nutritional supplements; Nutritional supplement for eliminating toxins from the body; Nutritionally fortified water for medical purposes; Nutritionally fortified beverages for medical purposes; Vitamin fortified beverages for medical purposes; Vitamin enriched chewing gum for medical purposes; Soy protein for use as a nutritional supplement in various powdered and ready-to-drink beverages; Nutritional supplement in the nature of a nutrient-denseprotein-based drink mix; Powdered nutritional supplement drink mix containing tannic acid; Nutritional supplements for catsdogs; Nutraceuticals for use as a dietary supplement for cognitive impairment; Nutraceuticals for the treatment of CNS disorders; Nutraceuticals for use as a dietary supplement
Publicações
Histórico de despachos e eventos da marca no USPTO.
46 publicações encontradas
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
21/01/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
30/03/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/01/2021
PUBO
PUBLISHED FOR OPPOSITION
12/01/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
23/12/2020
OTHE
CASE RETURNED TO EXAMINATION
09/12/2020
IUCN
NOTICE OF ALLOWANCE CANCELLED
09/12/2020
ATRQ
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
02/12/2020
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
02/12/2020
APET
ASSIGNED TO PETITION STAFF
01/12/2020
DOCK
ASSIGNED TO EXAMINER
02/11/2020
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
01/10/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
28/07/2020
EX3G
SOU EXTENSION 3 GRANTED
26/07/2020
EXT3
SOU EXTENSION 3 FILED
26/07/2020
EEXT
SOU TEAS EXTENSION RECEIVED
26/07/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
24/07/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
24/07/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
24/07/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
24/07/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
24/07/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
24/07/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/01/2020
EX2G
SOU EXTENSION 2 GRANTED
03/01/2020
EXT2
SOU EXTENSION 2 FILED
03/01/2020
EEXT
SOU TEAS EXTENSION RECEIVED
03/01/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
19/07/2019
EX1G
SOU EXTENSION 1 GRANTED
17/07/2019
EXT1
SOU EXTENSION 1 FILED
17/07/2019
EEXT
SOU TEAS EXTENSION RECEIVED
17/07/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
29/01/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/12/2018
PUBO
PUBLISHED FOR OPPOSITION
04/12/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
14/11/2018
ALIE
ASSIGNED TO LIE
27/10/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
15/10/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/10/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/10/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/10/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/09/2018
GNRT
NON-FINAL ACTION E-MAILED
05/09/2018
CNRT
NON-FINAL ACTION WRITTEN
05/09/2018
DOCK
ASSIGNED TO EXAMINER
30/08/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
18/05/2018
NWAP
NEW APPLICATION ENTERED
12/05/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace TANNQUILYNNE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.